Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunotherapy

Services, models of care, and interventions to improve access to cancer treatment for adults who are socially disadvantaged: A scoping review protocol

Tara C. Horrill, Amber Bourgeois, [ ... ], Kelli I. Stajduhar

Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer

Huanfei Ding, Bowen Hu, Ruixia Guo

A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia

Tingting Huang, Bernice Leung, [ ... ], Bonnie W. Lau

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy

Felix Peisen, Annika Gerken, [ ... ], Sergios Gatidis

Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma

Ren Li, Yang Chen, [ ... ], Geng Guo

Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data

Peng Wang, Qin Zhang, [ ... ], Zunyi Wang

Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy

Adib Miraki Feriz, Fatemeh Bahraini, [ ... ], Vito Racanelli

Longitudinal multi-functional analysis identified responses of T cells, B cells, and monocytes as hallmarks of immunotherapy tolerance in patients with merkel cell carcinoma

Quyuan Tao, Jia-xin Du, [ ... ], Xin-lin Chen

Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature

Hao Gu, Tingxuan Li, [ ... ], Junqi Liu

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC

Virginie Westeel, Wolfgang Schuette, [ ... ], Martin Reck

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

Kaoru Fujikawa, Takuro Saito, [ ... ], Hisashi Wada

Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma

Qian Feng, Hongcheng Lu, Linquan Wu

An enhanced three-stage design with trend analysis for allergen immunotherapy trials

Xinyu Tang, Ronald L. Rabin, Lihan K. Yan

Advertisement

Create a weekly email alert for: Immunotherapy

You can change these options by clicking profile then "Alerts and Notifications"